Objectives & Accreditation
The 2012 Stockholm meeting will focus on current and future therapy of Alzheimer’s disease. The world’s leaders in the field will discuss new trial designs, animal models, neuroimaging including PET and diagnostic recommendations as well as CSF and blood markers and their application to drug development. Emerging Novel Therapeutic Targets will be presented.
Neurologists, psychiatrists, geriatricians and pharmacologists.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Southern Illinois University School of Medicine, the University of Geneva, Geneva University Hospitals, and the Karolinska Institutet. The Southern Illinois University Schoolof Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Southern Illinois University School of Medicine designates this live activity for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.